Council Election Results

The results of the 2022 IGCS Council Election are in. The election was held online from April 18 - May 18. The results were verified by our third-party election software vendor, Simply Voting, Inc. and reviewed by the IGCS Secretary-Treasurer Elect, Dr. Rainer Kimmig, in accordance with IGCS policy.

For each position, the candidate receiving the most votes was elected. Regional Council Members were elected by IGCS Members residing in the corresponding region.

The new Council Members' terms will begin on October 1st at the close of the 2022 IGCS Annual Global Meeting in New York. View the current Council roster here.

President Elect

Prof. Greta Dreyer
Professor and Chair of Gynaecological Oncology
University of Pretoria
South Africa

Vice President

Dr. Anuja Jhingran
Professor, Department of Radiation Oncology, Division of Radiation Oncology
The University of Texas MD Anderson Cancer Center
United States

Secretary-Treasurer Elect

Prof. Ritu Salani
Professor Department of Obstetrics and Gynecology; Division Director of Gynecologic Oncology
University of California Los Angeles
United States

Council Member Positions

Candidates for regional Council Member positions were elected by IGCS Members residing within each respective region.

Africa/Middle East

Prof. David Atallah
Chairman of Obstetrics and Gynecology Department; Professor of Obstetrics and Gynecology
Hotel Deiu de France University Hospital; Saint Joseph University


Dr. Dilyara Kaidarova
Director of KazIOR
JSC Kazakh Institute of Oncology and Radiology

Americas (South/Central)

Dr. Audrey Tieko Tsunoda
Surgical Oncologist;  Gynecologic Oncology Department and Medical Director at IRCAD Latin America
Hospital Erasto Gaertner


Dr. Heleen van Beekhuizen MD, PhD, MSc clinical trials
Gynecological Oncologist, Head of Department  Gynaecological Oncology
Erasmus MC, Rotterdam
The Netherlands

Medical Oncologist

Dr. Fernando Maluf
Full Professor, BP Mirante

Congratulations to those elected and our appreciation goes out to all those who applied and ran for elected positions. With over fifty applicants for the eight open positions we are grateful for the many talented and dedicated members who are willing to volunteer their time and serve our society.

I'd also like to thank the members of the 2022 Nominating Committee for reviewing the applications and their thoughtful deliberations in developing the election slate.

I want to remind all of the applicants and members that Council service is only one way to contribute to our mission and there are many opportunities to participate in our educational initiatives, mentorship and training programs, and special projects. Becoming an engaged champion for our society's mission is the best pathway to becoming a future leader of the IGCS.

If you are a member who would like to give back to your society, and perhaps someday serve on the Council, we recommend that you reach out to IGCS CEO, Mary Eiken by emailing her at


Roberto Angioli, MD
IGCS Past President and Nominating Committee Chair

Project GEOCC

The International Gynecologic Cancer Society (IGCS) is embarking on an initiative to assess and address ovarian cancer care at a global level and has assembled an international steering committee called the Global Equality Group in Ovarian Cancer Care (GEGOCC) to conduct the assessment.

The goal of this project is to assess current practices, access to, and standards of care globally, and ultimately use this information to strive towards achieving equality and equity in care for all women affected by ovarian cancer.

Key items we are studying include:

  • use of national or international guidelines to inform ovarian cancer treatment recommendations
  • availability of quality registries
  • availability of multidisciplinary regional network agreements
  • availability of surgical training programs
  • utilization of surgical goals and documentation

Objectives of the study:

  • Knowing what resources are available and guidelines in place is extremely important to identify disparities in novel biologics and inform drug development for underserved areas.
  • Gathering data about key populations will ultimately help us inform the future of ovarian cancer clinical trial development in underserved communities.

If you are a clinician who cares for women diagnosed with ovarian cancer, we would be grateful if you would participate in our study by completing this survey. The survey will remain open until June 15. 

We ask that each clinician only completes the survey once and answers the questions with their individual practice patterns in mind.

The survey has been translated from English to Russian, Portuguese, Spanish, and Mandarin. Please chose the language you are most comfortable with and only complete the survey once.

GEOCC Steering Committee

Executive Committee 
Dr. Donal Brennan (Ireland)  
Dr. Robert Coleman (USA)  
Dr. Rhonda Farrell (Australia)  
Dr. Mario Leitao (USA) 
Dr. Sudha Sundar (UK)
Dr. Willemien van Driel (Netherlands) 
Dr. Oliver Zivanovic (USA) 

Steering Committee
Dr. Angeles Alvarez Secord (USA) 
Dr. David Atallah (Lebanon)
Dr. Glauco Baiocchi (Brazil) 
Dr. Aditi Bhatti (
Dr. Bill Cliby (USA)
Dr. SJ Chang (
South Korea) 
Dr. Nicole Concin (
Dr. Ignace de Hingh (Netherlands) 
Dr. Greta Dreyer (South Africa)

Dr. Andreas DuBois (Netherlands) 
Dr. Keiichi Fujiwara (Japan) 
Dr. Olivier Glehan (
Dr. Adrian HS Kim (South Korea) 
Dr. Jae-Weon Kim (South Korea) 
Dr. Brendan Moran (UK) 
Dr. Philippe Morrice (France) 
Dr. Asima Mukhopadhyay (India) 
Dr. Bakrin Naoual (France) 
Dr. Joseph Soon Yau Ng (Singapore) 
Dr. Angélica Nogueira Rodrigues (Brazil) 
Dr. Leslie Randall (USA) 
Dr. Beate Rau (Germany) 
Dr. Muhieddine Seoud (UAE)
Dr. Alexey Shevchuk (Russia) 
Dr. Ignace Vergote (Netherlands) 

IGCS 2022 Annual Global Meeting

It is our great pleasure to invite you to join us for the Annual Global Meeting of the International Gynecologic Cancer Society (IGCS 2022) to be held from September 29 through October 1, 2022, in New York City, USA.
Following the tradition of previous in-person meetings, IGCS 2022 will provide you with the opportunity to learn about the latest clinical advances as well as international developments in research, practice, and treatment for the holistic care of women with gynecological cancer.
It also serves as a great opportunity to network with colleagues from around the world.
We very much look forward to your participation in IGCS 2022
and to welcoming you to The Big Apple.
Brian Slomovitz, MD
Audrey Tsunoda, MD

Registration Now Open

IGCS will offer in-person and virtual registration options for the 2022 IGCS Annual Global Meeting
to be held September 29 - October 1.
Registration features a flexible approach to allow ease of converting between an in-person and virtual ticket.
Details between the options are outlined below.

Join us in NYC! 

IGCS looks forward to welcoming you to New York City! We are committed to the health and safety of our delegates, staff, and everyone who works at the meeting venue. We have been working closely with officials at the Javits Center, the professional conference organizer, and receiving updates from the New York government to ensure we gather in-person safely.
In-Person Registration Includes:
  • Access to multiple halls of live scientific programming
  • Ability to earn CME credits
  • Access to the Opening Ceremony and Annual IGCS Business Meeting
  • Access to networking events
  • Access to the sponsor conversation area (in lieu of exhibits)
  • Access to the surgical film & poster area including scheduled poster sessions
  • Refreshments during coffee breaks as indicated in the program
  • The opportunity to meet and network with speakers and colleagues
  • Option to attend the Annual Survivor-Caregiver Advocacy Summit
  • Access to all recorded sessions on-demand for 3 months post-meeting

Group Options

IGCS is pleased to offer Group Registration opportunities for IGCS 2022.
Please contact for more information.
Book your entire group—large or small—at one of the official IGCS hotels. If you are interested in booking a block of rooms, contact Irina Sapir at

Virtual Registration

IGCS is utilizing the latest virtual meeting technology to disseminate the most current gynecologic cancer research and clinical practice information to our delegates who are unable to travel.
Virtual Registration Includes:
  • Access to select scientific content live streamed from
  • New York City. These sessions will include the interactive question & answer segments, polling, and more.
  • Ability to claim CME credits for select sessions (must attend live stream to claim credits)
  • Access to all educational content on-demand for 3 months post-meeting
  • Access to abstracts/posters and surgical films online
  • Ability to view the Opening Ceremony live from New York City
  • Access to available Industry sessions featuring the latest research and technology
  • Virtual tours of New York City attractions

Housing In NYC

Reserve a room at one of the (8) official properties to secure discounted rooms for IGCS delegates.
Booking within one of the contracted properties supports IGCS in a variety of ways.
Perk! Most properties include breakfast for (1) in the room rate in addition to other incentives. Review the hotel options and book a reservation here.
The reservation deadline to secure the discounted rates is Monday, September 5, 2022.

Abstract Information

The abstract and surgical film submission site for IGCS 2022 is open and we welcome the opportunity to submit your current research and work related to these topics and themes in the field of gynecologic oncology.
  • Trials in Progress Abstract submission deadline: Monday, July 11, 2022, 11:59 pm ET.
  • Late-Breaking Abstract submission deadline: July 11, 2022, 11:59 pm ET
  • Oral, Poster, and Surgical Film submission deadline was Monday, May 9, 2022.
Please note, unlike years past, there will be no extensions for submission deadlines.

Introducing IGCS Advocacy Committee

With the addition of Globe-athon to End Women’s Cancers into the International Gynecologic Cancer Society (IGCS), we are pleased to announce that the IGCS has assembled an Advocacy Committee. The committee’s goal is to advance gynecologic cancer awareness in alignment with the IGCS mission by guiding, supporting, and overseeing the International Gynecologic Cancer Advocacy Network (IGCAN), as well as other advocacy initiatives, programs, and events.

The committee recently held their first call and will begin to guide the work within the three pillars and areas that support IGCAN:

  • Patient Education and Awareness
  • Advocacy Research and Science
  • Collaboration and Network Building

The programs and initiatives include:

  • Annual Survivor-Caregiver Advocacy Summit
  • Patient Perspectives Roundtable Series
  • Advocacy and Research Program
  • Uterine Cancer Survivorship Program
  • Cervical Cancer Survivorship Program
  • World Ovarian Cancer Coalition’s Every Woman Study™ Low- and Middle-income Edition
  • Formation of the International Gynecologic Cancer Advocacy Network

Advocacy Committee Members

Committee Chair: Daniela Luvero, MD (Italy)
Gynecologic Oncologist, University Campus Bio Medico of Rome

Committee Vice Chair: Rosalind Glasspool, MD (UK)
Medical Oncologist, NHS Greater Glasgow and Clyde and University of Glasgow

Mukhtasar Alkali (Nigeria)
Coordinator II at Medicaid Cancer Foundation Monitoring & Evaluation Officer on the Kebbi State Cervical Cancer Secondary Prevention Pilot Program

Adrienne Moore (USA)
Research Coordinator, University of Washington, Seattle
Respiratory Therapist
Patient Adviser & Ambassador, Endometrial Cancer Action Network African Americans (ECANA),  Endometrial Cancer Survivor

Geetu Bhandoria, MD (India)
Gynecologic Oncologist & Obstetrician, Indian Armed Forces

Nefa-Tari Moore (USA)
Outreach & Uterine Cancer Coordinator, SHARE Cancer Support
Two-time Uterine Cancer Survivor & Ovarian Cancer Survivor

Nicoletta Cerana (Italy)
President, ACTO - Alliance Against Ovarian Cancer

Maggie Nicholas-Alexander (USA)
Senior Director of Gynecologic Cancer Patient Support and Education, SHARE Cancer Support

Michele Collins (USA)
Board Member, Kaleidoscope of Hope Ovarian Cancer Foundation
Ovarian Cancer Survivor

Angélica Nogueira-Rodrigues, MD, PhD (Brazil)
Founder, Brazilian Group of Gynecology Oncology, EVA Group
Director, Brazilian Society of Medical Oncology
Researcher and Professor at Federal University, MG Brazil

Diane Crawford (USA)
Founder and Executive Director, The Crawford Crew
Cervical Cancer Survivor

Sandra Rosati (Italy)
President, Un Lago di Donne per la Prevenzione Oncologica
Cancer Survivor

Noriko Fujiwara, MS, RN, CRN-BC, OCNS, CCRP (Japan)
Research Nurse & Oncology Nurse, IMSUT Hospital of the Institute of Medical Science,
The University of Tokyo, Japan

Abhishek Shankar, MD (India)
Radiation Oncologist
Secretary, Indian Society of Clinical Oncology
Assistant Professor, Department of Preventive Oncology, AIIMS, New Delhi

Milicent Kagonga (Kenya)
Founder, Symbol of Hope Warriors
HPV Vaccine Ambassador
Cervical Cancer Survivor

Eva-Maria Strömsholm, MA, RN (Finland)
Co-Founder & Vice Chair, Gynecological Cancer Patients in Finland
Practical Nurse, Rare Ovarian Cancer Survivor

The committee members are breaking into workgroups to tackle each project including a network building group to brainstorm best strategies to build our noncompetitive network. The main goal is to link gynecologic cancer advocacy organizations and individual patient advocates—from every region, income, and resource setting—and create the opportunity for them to collaborate in achieving best outcomes for all gynecologic and breast cancer patients. Information regarding how to officially join the network is forthcoming.

We look forward to sharing more updates and information with you regarding our advocacy programs and how to officially join the IGCAN. There are a lot of exciting programs in development. Stay tuned!

Impact of the War in Ukraine on Cancer

May 13, 2022

Friends and Colleagues,

We continue to monitor and stay abreast of the situation in Ukraine and felt this was an opportune time to highlight some of the efforts of those working to address the healthcare crisis in the area.

Special Network
The IGCS leadership is participating a Special Network on the Impact of the War in Ukraine on Cancer established by the American Society of Clinical Oncology (ASCO) and the European Cancer Organization (ECO).  The Special Network recently held a meeting to discuss tangible actions that can be taken in collaboration with the WHO, EU and other organizations. The network includes over 300 organization representatives including medical societies, patient organizations, cancer centers, charities, foundations and the healthcare industry across the world.

The Special Network sent this statement to the WHO Europe Regional Committee to “highlight a range of needs that can be more fully met through inter-governmental attention and response” and to make them aware that the network is “ready and available to the WHO, governments, and others as a resource to connect stakeholders and the international and Ukrainian healthcare NGOs who are working tirelessly to address the emergency in Ukraine.”

IGCS will be participating in another Special Network meeting in June during the ASCO meeting in Chicago.

UICC Solidarity Fund
The Union for International Cancer Control (UICC) has established an emergency fund to bridge funding into the region to support the needs of cancer organizations struggling to serve patients affected by the conflict. The fund has received pledges of just over $1 million USD in donations and has opened a call for grants to qualifying organizations to allow those who qualify the opportunity to use the funds and assist in the region.  IGCS has donated to the fund, and we encourage others to consider joining us. Those who wish to donate to the emergency Solidarity Fund or apply for a grant to receive these funds can do so by contacting UICC at

Polish Gynecologic Cancer Society Efforts
We previously reported that IGCS has been in communication with our colleagues in Poland as they bear the heaviest burden of assisting patients and physicians in the region. This article, “War in Ukraine: the opportunities for oncogynecologic patients in Poland” recently published in the International Journal of Gynecological Cancer highlights the efforts of the Polish Society of Gynecologic Oncology in the coordination of treatment for Ukrainian patients with gynecological cancers.

“The cooperative initiative is run by both Polish and Ukrainian oncogynecologists and is based on the network of interpersonal contacts. The project aims to coordinate the arrival of patients in Poland, their accommodation, and allocating them to institutions where they receive appropriate treatment and support. Thanks to close cooperation between doctors from both sides of the border, the patients are not left without oncological care.”

To let them know about a patient in need, fill in the online form and visit the society’s website:

IGCS commends all who are working to address the issues and multifaceted challenges that have arisen for healthcare delivery in Ukraine and neighboring countries. We wholeheartedly support the statement from the Special Network on the Impact of the War in Ukraine to the WHO calling for solidarity among European countries to pool health service capacity and resources to prioritize those who have the greatest support needs and to make early preparations for the rebuilding of Ukrainian health services in the future.

Robert Coleman, MD
IGCS President

Mary Eiken, MS

March 9, 2022

Friends and Colleagues,

Last week IGCS released a statement regarding the unfolding situation in Ukraine. IGCS is fully committed to reducing human suffering from injury, trauma, and disease – anywhere in the world and especially now in Ukraine. Our leadership is currently examining ways that we can best respond to situations of conflict such as this to help offset the subsequent disruption to gynecologic cancer care services.

As UICC has reported, “the majority of people with cancer in conflict-affected areas are unable to get appropriate care, as regions become inaccessible, hospitals and health centres are damaged or destroyed and health workers are injured, killed or displaced. Health systems in neighbouring countries risk being overwhelmed by refugees fleeing these regions, at a time when they are already struggling with a backlog of cases due to the COVID-19 pandemic.”

These are a few of the recent developments and ongoing activities IGCS has and will participate in regarding the humanitarian efforts and support of Ukraine.

Support for our members and patients in the area
We are in direct communication with our colleagues in Poland and other surrounding regions where Ukraine citizens are fleeing to learn what assistance is needed regarding gynecologic cancer services for the displaced and how we can best contribute to their needs. As we learn more about these needs and how we might provide support, we will share specific information with our members about our response.

Collaborate with other organizations
The IGCS leadership has been invited to participate in a special meeting hosted by the American Society of Clinical Oncology (ASCO) and the European Cancer Organization (ECO) regarding the impact of the war in Ukraine on cancer. This meeting will focus on tangible actions that can be taken in collaboration with the WHO, EU and other organizations.

Donation to the UICC emergency solidarity fund
IGCS is a member of the Union for International Cancer Control (UICC) and they have established an emergency fund to bridge funding into the region to support the needs of cancer organizations struggling to serve patients affected by the conflict. IGCS has pledged $5,000 to the fund. If you wish to donate to the emergency Solidarity Fund, you can do so by contacting UICC at

We are encouraged by the outpouring of support from IGCS members and friends who are offering their aid in any way they can, to assist those in the medical community in Ukraine and the areas where many are fleeing.

Please see this summary list of humanitarian organizations that are already working in the region to make an impact and are actively seeking monetary and/or medical supply donations to help in the region. As more support opportunities become available, we will most certainly communicate these and if you would like to make us aware of any humanitarian organizations that could be added to the list, please email

IGCS is grateful to be so well-positioned in the global gynecologic oncology community to foster collaboration in this time of need among our members, friends, and colleagues. We continue to keep the people of Ukraine in our thoughts and prayers and are monitoring the situation closely. We appreciate our organizational associates and partners for reaching out to us to include us and by extension taking into consideration the needs of our patients in these efforts.


Robert Coleman, MD
IGCS President

Mary Eiken, MS

Interactive Updates on Selected Topics in Gynecology Oncology

Interactive Updates on Selected Topics in Gynecology Oncology

Recorded live on:
May 7 - Cervix Cancer
May 14 - Endometrial Cancer
May 21 - Ovarian Cancer
Presented in
Spanish, English &


Cervix Cancer | May 7
Moderated by Reitan Ribeiro
Surgical Treatment in cervical cancer - LACC trial impact
Pedro Ramirez 
Cervical cancer in pregnancy 
Aldo López Blanco 
Immunotherapy in cervical cancer: state-of-art 
Mauricio Lema  
Advances in radiation oncology for cervical cancer 
Anuja Jhingran 
Surgical treatment of advanced cervical cancer 
Renato Moretti-Marques
Endometrial Cancer | May 14
Moderated by Fernando Heredia
Historical evolution of lymph node assessment for endometrial cancer surgery 
Andrea Mariani 
Is there still a role for laparotomy in endometrial cancer? 
David Isla 
Up-to-date systemic therapy for endometrial cancer 
Eduardo Paulino 
Molecular classification and implications for therapy 
Angelica Nogueira-Rodrigues 
Controversies in radiation oncology for endometrial 
Hannah Simonds 
Technical aspects in endometrial cancer surgery 
Julian Di Guilmi 
Ovarian Cancer | May 21
Moderated by Fernando Maulf
Clinical selection for surgery in EOC 
Christina Fotopoulou 
Laparoscopic selection for surgery in EOC 
Giovanni Scambia 
How to incorporate PARPi in our practice? 
Michelle Samora 
Secondary cytoreduction in EOC 
Georgia Cintra 
Role of gynecologic oncology in BRCA testing 
Carlos Eduardo Andrade 


Audrey Tsunoda, MD
Fernando Maluf, MD
René Pareja, MD

World Ovarian Cancer Day

The Every Woman Study

The Every Woman StudyTM Low-and Middle-Income Edition
A joint initiative of the World Ovarian Cancer Coalition (Coalition) and the International Gynecologic Cancer Society (IGCS).

In 2018, the Coalition conducted the Every Woman StudyTM, the largest ever survey of women living with the disease. Over 1500 women from 44 countries responded, and the results have been presented at a number of international scientific meetings and published in the International Journal of Gynecological Cancer. This first survey mainly captured data from high-income countries.
The 2018 Study led to the development of the Global Ovarian Cancer Charter, outlining opportunities to make progress through the Charter’s six Global Goals.

To bridge the data gap from the first Study, the Coalition is partnering with IGCS to organize a ground-breaking low- and middle-income edition of the Every Woman Study™️. IGCS has been involved in this effort for the past year with IGCS CEO Mary Eiken (USA) and IGCS Member, Tracey Adams (South Africa) serving on the oversight committee. IGCS’ regional Strategic Alliance Partner groups and contacts from our Global Curriculum training sites have been receptive to our requests to help distribute the study to their patients.

With active interest from 31 countries, national leads, local leaders, administrators, and advocates will work on the ground to ensure optimal participation from women in their countries, resulting in an unprecedented data set that will help shape and guide local, regional, and national advocacy efforts in the hopes of reaching the Coalition’s goal of no woman being left behind.

Our hope is that the LMIC edition of the study will bring new insights and increase global collaboration to improve survival and quality of life for those affected by ovarian cancer.
The Every Woman Study™ Low and Middle-Income Edition is currently being translated into over 40 languages and undergoing ethics reviews. Data collection is expected to be conducted throughout the year with analysis beginning in 2023.

Patient Roundtable

Join us May 5th for the IGCS Virtual Patient Perspectives Roundtable: Overcoming Barriers to Genetic Testing in Ovarian Cancer. Speakers and panelists will bring their expertise and perspectives on genetic testing for ovarian cancer and discuss ways to we can advocate to overcome barriers, concerns, and challenges in this area.

With World Ovarian Cancer Day (May 8th) falling on the same day that many countries celebrate Mother’s Day this year, what a special occasion and event to bring the patient advocacy community together to talk openly about this important issue.

Overcoming Barriers to Genetic Testing in Ovarian Cancer

Thursday, May 5, 2022
7:00 am ET (New York)
Duration: 45 minutes
See all time zones.

Registration is FREE, but required.

Get Involved

Participating in the 10th World Ovarian Cancer Day couldn’t be easier!

It can be as simple as a social media post, encouraging others to learn and share information about ovarian cancer. Maybe you want to have a Teal event with friends or colleagues? Get everyone to have some fun with teal outfits and accessories – and, of course, post it for more awareness. Create your own signs, posters, etc., with the WOCC’s downloadable graphics, and then add your personal touch. By taking part in World Ovarian Cancer Day, you can help change the future of this disease by increasing awareness of symptoms and the need for more research. Together, we can reach our goal of #NoWomanLeftBehind

Download the #WOCD2022 Get Involved Guide on ways you can engage with this year’s campaign.

Patient Perspectives Roundtable

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 30- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.

Previous Roundtables

Overcoming Barriers to Genetic Testing in Ovarian Cancer
Recorded on May 5, 2022

Committing to Global Health Equity: More than a Statement
Recorded on December 16, 2021
Sponsored by GSK

Focus on Survivorship/Quality of Life and Patient-Reported Outcomes
Recorded on Friday, August 6, 2021
Sponsored by GSK

Spotlight on Endometrial Cancer: Breakthroughs & Concerns
Recorded on May 14, 2021
Sponsored by GSK

Navigating Telehealth/Telemedicine & Embracing Shared Decision Making
Recorded November 21, 2020
Sponsored by GSK

Patient Advocacy & Support in the Backdrop of COVID-19
Recorded June 30, 2020

Gynecologic Cancer Patient Care & Clinical Trials in the Midst of COVID-19
Recorded May 23, 2020
Sponsored by GOG Foundation

Educational Webinars

Upcoming Webinars

Advances & Updates Webinar:
Are Surgeons Collecting Enough Tumor Tissue in Laparoscopic Biopsies for HRD Testing?

Thursday, June 16, 2022
7:00 AM ET (New York)

Moderator: Tom Herzog, MD

Sponsored in part by Myriad

Recently Recorded

Advances & Updates Webinar:
Ocular Toxicities & Management of Other Adverse Events with ADC's

Recorded live on Tuesday, May 17, 2022

Moderator: Floor Backes, MD

Presenter: Gottfried E. Konecny, MD

Presenter: Mark Slabaugh, MD

Sponsored in part by Immunogen and Seagean

Advances & Updates Webinar:
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer

Recorded live on Tuesday, May 10, 2022

Presenter: Vicky Makkers, MD

Advances & Updates Webinar:
SORAYA Trial Data with Dr. Ursula A. Matulonis

Recorded live on Wednesday, May 4, 2022

Presenter: Ursula Matulonis, MD

Moderator: Robert Coleman, MD

Sponsored in part by Immunogen.

Preinvasive Disease Certificate Program

Preinvasive Disease

The IGCS Preinvasive Certificate Program provides a framework for basic training in preinvasive disease of the female lower genital tract. It is a learning opportunity originating from the needs of the trainees enrolled in the IGCS Global Curriculum and Mentorship Program but it’s also a great educational tool to enhance clinical knowledge and skills in preinvasive cervical disease management for all health care providers in any setting

Aims and Objectives

  • To provide an important educational tool that will help train clinicians so that we can meet the goals and objectives of the WHO Global Strategy to eliminate cervical cancer
  • To build and enhance the knowledge and skills of medical providers all over the world on HPV, HPV vaccination, cervical screening methods and strategies including the diagnosis and treatment of preinvasive cervical disease
  • To equip IGCS members with evidence-based knowledge for preventing, screening, diagnosing, and treating patients with preinvasive cervical diseases regardless of the setting they work in

Target Audience
Physicians including gynecologic oncologists, gynecologists, family medicine doctors, general doctors, nurse practitioners, physician assistants, nurses, and other healthcare providers who are already involved or keen to be involved in the prevention and treatment of cervical cancer and other HPV related diseases.

The program will be delivered in three phases:

  • Phase 1: Basic Theory (self-guided education)
  • Phase 2: Advanced Theory (self-guided education)
  • Phase 3: Practical/Competence Assessment (hands-on training)

The first opportunity for hands-on training will be provided at the IGCS Annual Global Meeting in New York on September 28, 2022. Additional training dates and locations will be announced.

All three phases must be completed before the learner will receive a certificate of completion for technical competency in colposcopy and treatment of preinvasive cervical disease. Learners who complete only phases 1 and 2 will receive a certificate of knowledge that does not certify technical competency.

View additional details and requirements about the preinvasive disease curriculum.

Those who enroll will receive an email with instructions how to access the course within 24 hours. To optimize your experience, please clear your browsing history and cookies prior to beginning the course. The recommended web browser is Google Chrome.

Mila Pontremoli Salcedo, MD, PhD
Ida Ismail-Pratt, MBChB, MRCOG

Ellen S. Baker, MD, MPH
James Bentley, MBChB, FRCSC
Julia Brotherton, PhD
Maggie E. Cruickshank, MD
Gustavo Ruvino De Azevedo Focchi, MD, PhD
Suzanne Garland, AO, MBBS, MD, FRCPA, FRANZCOG Ad Eundem, FAChSHM, FASM, FACOG Hons

Jose Jeronimo, MD
Rachel Masch, MD, MPH
Jane R. Montealegre, PhD, MSPH
Joseph Ng, MD, FACOG, FAMS
Katina Robison, MD
Kathleen Schmeler, MD
Erich Madison Sturgis, MD, MPH
Melissa Lopez Varon M.Sc.
Alan G. Waxman, MD, MPH